30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Eiry Roberts

Track

Insider profile

Currently holds a position at Neurocrine Biosciences Inc

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Neurocrine Biosciences Inc Jan. 8, 2018 -
Eiry Roberts's trades of Neurocrine Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-14
PrS Proposed sale
18,643
140.45
US$4,064,032 		18,643 140.45 US$4,064,032
2025-02-14 2025-02-14
S Sale
93,598 +22.1%
272.14
US$4,837,893 		93,598 +22.1% 272.14 US$4,837,893
2025-02-14 2025-02-13
PlS Planned sale
20,256 +3.1%
341.89
US$4,527,392 		20,256 +3.1% 341.89 US$4,527,392
2025-02-14 2025-02-13
PlS Planned sale
1,114 -3.1%
116.90
US$130,232 		1,114 -3.1% 116.90 US$130,232
2025-02-13 2025-02-13
PrS Proposed sale
604
117.18
US$70,777 		604 117.18 US$70,777
2025-02-13 2025-02-13
PrS Proposed sale
1,114
117.18
US$130,539 		1,114 117.18 US$130,539
2025-02-12 2025-02-10
PlS Planned sale
980 -2.9%
118.22
US$115,853 		980 -2.9% 118.22 US$115,853
2025-02-10 2025-02-10
PrS Proposed sale
980
122.62
US$120,168 		980 122.62 US$120,168
2025-02-04 2025-01-31
PlS Planned sale
1,457 -4.3%
152.80
US$222,636 		1,457 -4.3% 152.80 US$222,636
2025-01-31 2025-01-31
PrS Proposed sale
1,457
153.29
US$223,344 		1,457 153.29 US$223,344
2024-02-15 2024-02-13
PlS Planned sale
1,114 -4.5%
132.96
US$148,122 		1,114 -4.5% 132.96 US$148,122
2024-02-13 2024-02-13
PrS Proposed sale
1,114
130.43
US$145,299 		1,114 130.43 US$145,299
2024-02-08 2024-02-08
PlS Planned sale
980 -4.1%
134.21
US$131,522 		980 -4.1% 134.21 US$131,522
2024-02-08 2024-02-06
PlS Planned sale
1,121 -4.9%
142.24
US$159,446 		1,121 -4.9% 142.24 US$159,446
2024-02-06 2024-02-06
PrS Proposed sale
2,101
141.66
US$297,628 		2,101 141.66 US$297,628
2024-02-02 2024-01-31
PlS Planned sale
1,457 -6.5%
140.79
US$205,132 		1,457 -6.5% 140.79 US$205,132
2024-01-31 2024-01-31
PrS Proposed sale
1,457
142.06
US$206,981 		1,457 142.06 US$206,981
2023-12-27 2023-12-22
PlS Planned sale
10,000 -33.9%
126.74
US$1,267,448 		10,000 -33.9% 126.74 US$1,267,448
2023-12-22 2023-12-22
PrS Proposed sale
10,000
121.16
US$1,211,600 		10,000 121.16 US$1,211,600
2023-12-14 2023-12-12
PlS Planned sale
6,947 -19.0%
120.31
US$835,779 		6,947 -19.0% 120.31 US$835,779
2023-12-14 2023-12-12
PlS Planned sale
6,978 -19.1%
120.30
US$839,461 		6,978 -19.1% 120.30 US$839,461
2023-12-11 2023-12-08
PlS Planned sale
100 -0.3%
120.00
US$12,000 		100 -0.3% 120.00 US$12,000
2023-12-11 2023-12-08
PlS Planned sale
200 -0.7%
120.16
US$24,031 		200 -0.7% 120.16 US$24,031
2023-12-11 2023-12-07
PlS Planned sale
11,775 -28.5%
120.37
US$1,417,374 		11,775 -28.5% 120.37 US$1,417,374
2023-12-11 2023-12-07
PlS Planned sale
14,140 -32.4%
120.37
US$1,702,053 		14,140 -32.4% 120.37 US$1,702,053
2023-12-11 2023-12-07
PlS Planned sale
12,742 -30.1%
120.37
US$1,533,774 		12,742 -30.1% 120.37 US$1,533,774
2023-12-11 2023-12-07
PlS Planned sale
38,722 -56.7%
120.37
US$4,661,118 		38,722 -56.7% 120.37 US$4,661,118
2023-12-08 2023-12-06
PlS Planned sale
8,396 -22.1%
120.03
US$1,007,780 		8,396 -22.1% 120.03 US$1,007,780
2023-12-06 2023-12-06
PrS Proposed sale
100,000
118.54
US$11,854,000 		100,000 118.54 US$11,854,000
2023-08-22 2023-08-22
PrS Proposed sale
3,198
108.32
US$346,407 		3,198 108.32 US$346,407
2023-08-23 2023-08-21
PlS Planned sale
3,198 -9.8%
107.38
US$343,388 		3,198 -9.8% 107.38 US$343,388
2023-04-26 2023-04-24
PlS Planned sale
14,400 -35.1%
103.48
US$1,490,059 		14,400 -35.1% 103.48 US$1,490,059
2023-04-24 2023-04-24
PrS Proposed sale
14,400
104.17
US$1,500,048 		14,400 104.17 US$1,500,048
2023-02-08 2023-02-08
PlS Planned sale
980 -2.3%
104.16
US$102,072 		980 -2.3% 104.16 US$102,072
2023-02-08 2023-02-07
PlS Planned sale
12,801 -24.2%
102.41
US$1,310,918 		12,801 -24.2% 102.41 US$1,310,918
2023-02-08 2023-02-07
PlS Planned sale
1,623 -5.4%
102.35
US$166,114 		1,623 -5.4% 102.35 US$166,114
2023-02-08 2023-02-06
PlS Planned sale
1,121 -4.0%
105.80
US$118,602 		1,121 -4.0% 105.80 US$118,602
2023-02-02 2023-01-31
PlS Planned sale
1,457 -5.3%
109.99
US$160,254 		1,457 -5.3% 109.99 US$160,254
2022-02-09 2022-02-08
PlS Planned sale
980 -3.8%
79.52
US$77,931 		980 -3.8% 79.52 US$77,931
2022-02-09 2022-02-07
PlS Planned sale
1,121 -4.5%
80.80
US$90,574 		1,121 -4.5% 80.80 US$90,574
2022-02-09 2022-02-07
PlS Planned sale
1,623 -6.7%
80.77
US$131,086 		1,623 -6.7% 80.77 US$131,086
2022-01-12 2022-01-10
PlS Planned sale
2,632 -11.0%
74.50
US$196,088 		2,632 -11.0% 74.50 US$196,088
2021-02-09 2021-02-08
PlS Planned sale
1,623 -8.0%
116.83
US$189,607 		1,623 -8.0% 116.83 US$189,607
2021-02-09 2021-02-08
PlS Planned sale
740 -4.1%
116.67
US$86,337 		740 -4.1% 116.67 US$86,337
2021-01-12 2021-01-08
PlS Planned sale
2,632 -14.2%
111.06
US$292,297 		2,632 -14.2% 111.06 US$292,297